HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Hua He Selected Research

vitexin

6/2018Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1.
4/2017Vitexin protects against hypoxic-ischemic injury via inhibiting Ca2+/Calmodulin-dependent protein kinase II and apoptosis signaling in the neonatal mouse brain.
12/2016A review on the pharmacological effects of vitexin and isovitexin.
12/2015Vitexin reduces hypoxia-ischemia neonatal brain injury by the inhibition of HIF-1alpha in a rat pup model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Hua He Research Topics

Disease

5Epilepsy (Aura)
10/2021 - 01/2017
5Ischemia
11/2019 - 12/2015
5Hypoxia (Hypoxemia)
01/2019 - 07/2013
3Atrophy
05/2019 - 12/2015
3Brain Injuries (Brain Injury)
06/2018 - 12/2015
3Febrile Seizures (Febrile Seizure)
08/2015 - 06/2012
2Seizures (Absence Seizure)
01/2022 - 01/2014
2Status Epilepticus (Complex Partial Status Epilepticus)
10/2021 - 01/2021
2Infarction (Infarctions)
05/2019 - 12/2015
2Neoplasms (Cancer)
12/2016 - 01/2014
1Lymphoma (Lymphomas)
01/2022
1Pulmonary Hypertension
01/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021
1Inflammation (Inflammations)
06/2018
1Brain Infarction
04/2017
1Brain Edema (Cerebral Edema)
12/2015
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2015
1Shellfish Poisoning
09/2013
1Ciguatera Poisoning (Ciguatera)
09/2013
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
08/2012
1Virus Diseases (Viral Diseases)
05/2012
1Infections
05/2012
1Stomach Neoplasms (Stomach Cancer)
10/2011
1Carcinoma (Carcinomatosis)
02/2004
1Cardiac Arrhythmias (Arrythmia)
09/2002

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2012
4vitexinIBA
06/2018 - 12/2015
3CytokinesIBA
11/2019 - 06/2012
2Circular RNAIBA
01/2021 - 01/2021
2Oxygen (Dioxygen)IBA
11/2019 - 05/2019
2Glucose (Dextrose)FDA LinkGeneric
11/2019 - 05/2019
2Messenger RNA (mRNA)IBA
08/2015 - 01/2014
2PotassiumIBA
01/2014 - 07/2013
1pegaspargase (Oncaspar)FDA Link
01/2022
14-Aminopyridine (4 Aminopyridine)FDA Link
01/2022
1Asparaginase (Elspar)FDA Link
01/2022
1anlotinibIBA
01/2022
1Complement C3 (C3 Complement)IBA
10/2021
1Competitive Endogenous RNAIBA
01/2021
1Methotrexate (Mexate)FDA LinkGeneric
01/2021
1Ion Channels (Ion Channel)IBA
11/2019
1triphenyltetrazoliumIBA
05/2019
1ElementsIBA
01/2019
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
04/2017
1Pentylenetetrazole (Metrazol)IBA
01/2017
1K Cl- CotransportersIBA
01/2017
1Bumetanide (Bumex)FDA LinkGeneric
01/2017
1AntioxidantsIBA
12/2016
1Neuroprotective AgentsIBA
12/2016
1Immunoglobulin G (IgG)IBA
12/2015
1oxalylglycineIBA
12/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2015
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1Potassium Channels (Potassium Channel)IBA
01/2014
1Scorpion Venoms (Scorpion Venom)IBA
09/2013
1Botulinum Toxins (Botulinum Toxin)IBA
09/2013
1Spider Venoms (Venom, Spider)IBA
09/2013
1VenomsIBA
09/2013
1ZincIBA
07/2013
1Peptides (Polypeptides)IBA
08/2012
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2011
1Caspase 3 (Caspase-3)IBA
10/2011
1AconitineIBA
09/2002
1SodiumIBA
09/2002

Therapy/Procedure

2Radiotherapy
01/2022 - 02/2004
1Ligation
12/2015
1Induced Hyperthermia (Thermotherapy)
08/2015
1Resistance Training
01/2015
1Cardiac Rehabilitation
01/2015
1Drug Therapy (Chemotherapy)
10/2011
1Therapeutics
10/2011